Back

Impact of prosthesis choice on mortality after transfemoral transcatheter aortic valve implantation in patients with reduced- versus preserved- left-ventricular ejection fraction

3 September 2019 (14:00 - 18:00)
Organised by:
Congress Presentation Part of: Poster Session 7 - Other aspects in Valvular Heart Disease and in pulmonary hypertension Intervention ESC Premium Access ESC Congress 2019

About the speaker

Photo
Doctor Karim El Chilali

Prosper-Hospital, Recklinghausen (Germany)

11 More presentations in this session

Presentation thumbnail
Doctor A. Vijiiac (Bucharest, RO)
Abstract
Presentation thumbnail
Ms L. Rodriguez (Barcelona, ES)
Abstract
Presentation thumbnail
Associate Professor R. Kockova (Hradec Kralove, CZ)
Abstract Slides
Presentation thumbnail
Presentation thumbnail
Doctor Y. ZHENG (Beijing, CN)

Access the full session

Session thumbnail
Poster Session 7 - Other aspects in Valvular Heart Disease and in pulmonary hypertension

The Event

Event poster

ESC Congress 2019

3 September 2019 14:00 CET
You may be interested in
thumbnail
Congress Presentation
Outcomes of TAVI in patients with heart failure with reduced ejection fraction
20 May 2023
thumbnail
Congress Presentation
Real-world comparison of the last generation balloon-expandable and self-expanding valves in patients undergoing TAVI.
27 August 2021
thumbnail
Congress Presentation
Comparative prognostic impact of paravalvular leak versus permanent pacemaker implantation after transcatheter aortic valve implantation without reduced ejection fraction patients
30 August 2026
thumbnail
Congress Presentation
Echocardiographic assessment of functional changes of prosthetic valve after transcatheter aortic valve implantation in one year follow up: Insights from the multicenter, randomized DIRECT trial.
28 August 2020

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources